Alternatives to QED Science

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

AI platform for accelerating novel peptide therapeutic discovery and development.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.